Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Pediatrix Medical (MD) over the last 16 years, with Q3 2025 value amounting to $71.7 million.

  • Pediatrix Medical's Net Income towards Common Stockholders rose 26884.93% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 22519.2%. This contributed to the annual value of $3.8 million for FY2022, which is 8358.61% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Net Income towards Common Stockholders is $71.7 million, which was up 26884.93% from $39.3 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Net Income towards Common Stockholders peaked at $71.7 million during Q3 2025, and registered a low of -$153.0 million during Q2 2024.
  • Moreover, its 4-year median value for Net Income towards Common Stockholders was $5.7 million (2022), whereas its average is $4.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 586995.31% in 2021, then crashed by 17961.14% in 2022.
  • Over the past 4 years, Pediatrix Medical's Net Income towards Common Stockholders (Quarter) stood at $7.2 million in 2021, then fell by 21.77% to $5.7 million in 2022, then soared by 438.61% to $30.5 million in 2024, then surged by 135.26% to $71.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at $71.7 million for Q3 2025, versus $39.3 million for Q2 2025 and $20.7 million for Q1 2025.